Companion Diagnostics (CDx) in Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement

We are pleased to invite you to the “3rd Annual Summit Companion Diagnostics (CDx) in Oncology & Beyond: Clinical Applications, Regulation, & Reimbursement” scheduled for October 26th - 27th, 2017 in Vienna, Austria.

This premier B2B event provides the appropriate platform to engage and discuss ideas with your fellow peers, while facilitating a professional atmosphere and environment for good company representation and development.

The summit will shed light on current challenges, best practices and the inside view of the future of Companion Diagnostics. We will discuss key findings, including critical insights, as well as recommendations for driving efficient strategies in Companion Diagnostics landscape.

It is an honor and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna upcoming October!

Key Practical Learning Points of the Summit:

  • Emerging tools and discoveries to advance Companion Diagnostics (CDx) adoption
  • CDx, complimentary diagnostics (CoDx), and multiplexed CDx for precisely targeted population groups
  • Optimised drug & diagnostics co-development road map
  • Efficient regulation, reimbursement, & partnerships within the CDx landscape for oncology and beyond

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:

  • Companion Diagnostics
  • Molecular Diagnostics
  • Personalised Healthcare
  • Biomarkers
  • Medical Sciences
  • Experimental Medicine
  • Translational Medicine
  • Clinical Development
  • Clinical Trials
  • Regulatory
  • Commercialisation
  • Market Access
  • Payers
  • Patient Advocates
  • Insurers
  • Genomics
  • Immunology
  • Oncology
  • Non-oncology
  • Rare Diseases
  • Drug Development
  • Research
Speakers